Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
glycogen storage disease/obesitat
L'enllaç es desa al porta-retalls
Pàgina 1 des de 33 resultats
Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Type Ia Glycogen storage disease is an autosomal recessive hepatic metabolic disease due to a lack of glucose-6-phosphatase (G-6-Pase) activity presenting with growth retardation, lactic acidosis, fasting hypoglycemia with hypoinsulinemia, hyperuricemia, hepatomegaly, and hepatic adenoma with a risk
Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease (GSD) type I is characterized by impaired production of glucose from glycogenolysis and gluconeogenesis resulting in severe hypoglycaemia and increased production of lactic acid, triglyceride and uric acid. The most common type, glycogenosis type Ia, demands a balanced,
Bariatric surgery is not contraindicated in obese patients suffering from glycogen storage disease type IXa. A case report with follow-up at three years.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Glucose storage disease type IXa (GSD IXa) is an uncommon condition presenting with childhood onset hepatomegaly, growth retardation, and often, fasting ketosis and hypoglycemia. Despite its benign course, the lack of dietary counseling may favor uncontrolled weight gain. We investigated
Familial cardiac glycogen storage disease; associated hereditary maternal diabetes mellitus and obesity.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease type I: clinical and laboratory profile.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE
To characterize the clinical, laboratory, and anthropometric profile of a sample of Brazilian patients with glycogen storage disease type I managed at an outpatient referral clinic for inborn errors of metabolism.
METHODS
This was a cross-sectional outpatient study based on a convenience
Fatty Liver Caused by Glycogen Storage Disease Type IX: A Small Series of Cases in Children.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This study was undertaken to test the glycemic response of five infants with glycogen storage disease type 1, aged 0.7 to 1.5 years, to uncooked cornstarch under various dietary conditions, and to evaluate the long-term effects of a dietary regimen consisting of uncooked cornstarch in milk every 4
Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease type-Ia (GSD-Ia) is caused by a lack of glucose-6-phosphatase-α (G6Pase-α or G6PC) activity. We have shown that gene therapy mediated by a recombinant adeno-associated virus (rAAV) vector expressing human G6Pase-α normalizes blood glucose homeostasis in the global G6pc
Glycogen storage disease presenting as Cushing syndrome.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Impaired growth is common in patients with glycogen storage disease (GSD), who also may have "cherubic" facies similar to the "moon" facies of Cushing syndrome (CS). An infant presented with moon facies, growth failure, and obesity. Laboratory evaluation of the
Glycogen storage disease type Ia mice with less than 2% of normal hepatic glucose-6-phosphatase-α activity restored are at risk of developing hepatic tumors.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease type Ia (GSD-Ia), characterized by impaired glucose homeostasis and chronic risk of hepatocellular adenoma (HCA) and carcinoma (HCC), is caused by a deficiency in glucose-6-phosphatase-α (G6Pase-α or G6PC). We have previously shown that G6pc-/- mice receiving gene transfer
Living donor liver transplantation for glycogen storage disease type Ib.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease type 1b (GSD-1b) is due to an autosomal recessive inborn error of carbohydrate metabolism caused by defects in glucose-6-phosphatase translocase. Patients with GSD-1b have severe hypoglycemia with several clinical manifestations of hepatomegaly, obesity, a doll-like face,
Usefulness of chemical-shift MRI in discriminating increased liver echogenicity in glycogenosis.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Glycogen storage diseases are inherited defects which cause accumulation of glycogen in the tissues. Hepatic steatosis is defined as accumulation of fat within hepatocytes. On sonography, liver shows increased echogenicity both in glycogen storage diseases and steatosis. Liver
Hepatic glycogen storage diseases are associated to microbial dysbiosis.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Liver-directed gene therapy for murine glycogen storage disease type Ib.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease type-Ib (GSD-Ib), deficient in the glucose-6-phosphate transporter (G6PT), is characterized by impaired glucose homeostasis, myeloid dysfunction, and long-term risk of hepatocellular adenoma (HCA). We examined the efficacy of G6PT gene therapy in G6pt-/- mice using
Long-term Outcomes of Living Donor Liver Transplantation for Glycogen Storage Disease Type 1b.
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Glycogen storage disease (GSD) type 1b (OMIM 232220) is an autosomal recessive inborn error of carbohydrate metabolism caused by defects in glucose-6-phosphatase translocase (G6PT). GSD1b patients have severe hypoglycemia with several clinical manifestations of hepatomegaly, obesity, a doll-like
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
